jcm-logo

Journal Browser

Journal Browser

Application of Interventional Therapy in Cardiovascular and Cerebrovascular Diseases

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiovascular Medicine".

Deadline for manuscript submissions: closed (30 November 2024) | Viewed by 3444

Special Issue Editor


E-Mail Website
Guest Editor
Department of Clinical and Experimental Medicine, Section of Cardiology, University of Messina, and Azienda Ospedaliera Universitaria Policlinico "Gaetano Martino", Messina, Italy
Interests: heart failure; myocardial infarction; echocardiography; acute myocardial infarction; atrial fibrillation; cardiovas-cular medicine; clinical cardiology; electrocardiography; atherosclerosis; hypertension
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue presents a comprehensive overview of the advances and application of interventional therapy in the treatment of cardiovascular and cerebrovascular diseases. It covers a wide range of topics, including the latest techniques and technologies, clinical studies, outcomes, and challenges in interventional therapy.

The key topics covered in this Special Issue include the role of interventional therapies for acute myocardial infarctions, coronary artery disease, stroke, carotid artery disease, peripheral artery disease, pulmonary embolism, and hypertension. It also discusses the development of minimally invasive procedures, such as percutaneous coronary intervention, endovascular therapy, and transcatheter aortic valve replacement, and their significant impact on patients’ outcomes.

The studies presented in this Special Issue highlight the benefits of interventional therapy in improving patients’ survival rates, reducing complications, and enhancing the quality of life for individuals suffering from cardiovascular and cerebrovascular diseases. Additionally, this Special Issue sheds light on the challenges faced by healthcare professionals in successfully implementing and optimizing interventional therapy techniques, including patient selection, risk stratification, and individualized treatment plans.

In conclusion, this Special Issue serves as a valuable resource for healthcare professionals and researchers interested in advancing the field of interventional therapy for cardiovascular and cerebrovascular diseases. The studies and insights presented not only provide a deeper understanding of the latest techniques and technologies but also emphasize the need for continuous research and development in this field.

Dr. Giuseppe Ando
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • interventional therapy
  • cardiovascular diseases
  • cerebrovascular diseases
  • acute myocardial infarction
  • coronary artery disease
  • stroke
  • carotid artery disease
  • peripheral artery disease
  • percutaneous coronary intervention
  • endo-vascular therapy
  • transcatheter aortic valve replacement
  • pulmonary embolism
  • renal denervation
  • patient out-comes

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 12686 KiB  
Article
Title: Is Celiac Trunk Revascularization Necessary After High-Flow Pancreaticoduodenal Arterial Arcades Aneurysm Retrograde Embolization?
by Mohamed Salim Jazzar, Hicham Kobeiter, Mario Ghosn, Raphael Amar, Youssef Zaarour, Athena Galletto Pregliasco, Pascal Desgranges, Vania Tacher, Mostafa El Hajjam and Haytham Derbel
J. Clin. Med. 2024, 13(23), 7063; https://doi.org/10.3390/jcm13237063 - 22 Nov 2024
Cited by 1 | Viewed by 1370
Abstract
Background and Objective: High-flow pancreaticoduodenal artery (PDA) aneurysms secondary to celiac trunk occlusion or stenosis have a high risk of rupture. Embolization offers a less invasive alternative to surgery. We evaluated the effectiveness and safety of retrograde embolization via the superior mesenteric artery [...] Read more.
Background and Objective: High-flow pancreaticoduodenal artery (PDA) aneurysms secondary to celiac trunk occlusion or stenosis have a high risk of rupture. Embolization offers a less invasive alternative to surgery. We evaluated the effectiveness and safety of retrograde embolization via the superior mesenteric artery of high-flow PDA aneurysms without celiac trunk revascularization. Methods: This retrospective bicentric study included patients who underwent embolization of high-flow PDA aneurysms due to significant celiac trunk stenosis or occlusion. All patients underwent pre-interventional dynamic contrast-enhanced computed tomography. Retrograde embolization was performed using microcoils and/or liquid agents without celiac trunk revascularization. Follow up involved clinical and radiological assessment at one month. Technical and clinical success were evaluated, and complications were categorized as minor or major. Results: Twenty-three patients (mean age 65 ± 14 years; 52% male) were included. Emergency embolization was required in 12 patients (52%). The technical success rate was 100%. Patients were monitored for a median of 16 months. Clinical success was 87%. No hemorrhagic recurrences were observed. Minor complications occurred in two cases. One major complication involved splenic infarction due to glue migration, requiring splenectomy and intensive unit care admission. Conclusions: Retrograde embolization of high-flow PDA aneurysms is effective and safe without needing celiac trunk revascularization. Full article
Show Figures

Figure 1

12 pages, 4519 KiB  
Article
Endovascular Recanalization and Carotid Stenting: The New Approach to Restore Cerebral Perfusion during Aortic Dissection
by Maxim Agarkov, Kirill Kozlov, Ekaterina Senkina, Sergey Gornov, Natalia Linkova, Elena Kechaeva, Dmitrii Medvedev, Alexander Krasichkov, Anastasiia Dyatlova and Victoria Polyakova
J. Clin. Med. 2024, 13(9), 2716; https://doi.org/10.3390/jcm13092716 - 6 May 2024
Viewed by 1518
Abstract
A type A aortic dissection (TAAD) is a dangerous condition requiring emergency surgery. Due to the similarity of the symptoms of cerebral malperfusion in TAAD and the signs of ischemic stroke, a differential diagnosis of these diseases is not always available. Patients with [...] Read more.
A type A aortic dissection (TAAD) is a dangerous condition requiring emergency surgery. Due to the similarity of the symptoms of cerebral malperfusion in TAAD and the signs of ischemic stroke, a differential diagnosis of these diseases is not always available. Patients with TAAD after cerebral malperfusion can have a neurological deficit. Thrombolysis is performed in this case. It can worsen the patient’s condition and increase the risk of mortality and disability. The aim of the study is to evaluate the new approach to restoring cerebral perfusion during aortic dissection. This approach includes endovascular recanalization and carotid stenting. Methods: Two clinical cases of TAAD complicated by cerebral malperfusion are described. The first patient is 73 years old and was admitted as planned to perform transcatheter aortic valve implantation (TAVI) for grade III aortic stenosis. The patient underwent transcatheter aortic valve implantation (TAVI) on the second day after admission. The second patient is 60 years old and was hospitalized by an ambulance with strong hypertension and ischemia. The surgical correction of aortic dissection was postponed until the neurological status assessment in both patients. Results: The surgery to correct the aorta dissection was deemed inappropriate. The carotid arteries have been reanalyzed, and cerebral perfusion has been restored in a short time in both patients. Conclusion: Acute bilateral internal carotid occlusion is a potentially fatal TAAD outcome. Emergency endovascular recanalization and carotid stenting may be considered one of the few ways to restore cerebral perfusion. Full article
Show Figures

Figure 1

Back to TopTop